Merck Kgaa
(MRK.D.DX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 5,213,000 | 4,973,000 | 4,870,000 | 4,631,000 | 4,598,000 |
| Cost of Goods | 1,959,000 | 1,859,000 | 1,813,000 | 1,721,000 | 1,795,000 |
| Gross Profit | 3,254,000 | 3,114,000 | 3,057,000 | 2,910,000 | 2,803,000 |
| Operating Expenses | 2,204,000 | 2,067,000 | 2,007,000 | 1,861,000 | 2,367,000 |
| Operating Income | 1,050,000 | 1,047,000 | 1,050,000 | 1,049,000 | 436,000 |
| Interest Expense | 24,000 | 77,000 | 109,000 | 84,000 | 60,000 |
| Other Income | -34,000 | 23,000 | 14,000 | 19,000 | 183,000 |
| Pre-tax Income | 992,000 | 993,000 | 955,000 | 984,000 | 559,000 |
| Income Tax | 186,000 | 229,000 | 208,000 | 236,000 | 119,000 |
| Net Income Continuous | 807,000 | 764,000 | 747,000 | 748,000 | 441,000 |
| Minority Interests | -4,000 | -3,000 | -2,000 | -1,000 | -5,000 |
| Net Income | $802,000 | $761,000 | $745,000 | $747,000 | $436,000 |
| EPS Basic Total Ops | 1.85 | 1.75 | 1.71 | 1.72 | 1.00 |
| EPS Basic Continuous Ops | 1.85 | 1.75 | 1.71 | 1.72 | 1.00 |
| EPS Diluted Total Ops | 1.85 | 1.75 | 1.71 | 1.72 | 1.00 |
| EPS Diluted Continuous Ops | 1.85 | 1.75 | 1.71 | 1.72 | 1.00 |
| EBITDA(a) | $1,491,000 | $1,513,000 | $1,483,000 | $1,492,000 | $1,115,000 |